Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Executive Team
    • Board of Directors
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media
  • Training Videos

Press Releases

Dec 17, 2019

Aethlon Medical Announces Closing of $5 Million Public Offering

Dec 13, 2019

Aethlon Medical Announces Pricing of $5 Million Public Offering

Nov 1, 2019

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Oct 29, 2019

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019

Oct 14, 2019

Aethlon Announces Reverse Stock Split

Oct 7, 2019

Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications

Oct 3, 2019

Aethlon Medical Receives Extension from Nasdaq to Regain Compliance with Continued Listing Requirements

Sep 24, 2019

Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance

Sep 16, 2019

Aethlon Medical Receives National Cancer Institute Contract Award

Aug 14, 2019

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...21
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2023 Aethlon Medical, Inc. All Rights Reserved.